Latest news with #macroEnvironment
Yahoo
a day ago
- Business
- Yahoo
Revvity price target lowered to $110 from $116 at BofA
BofA lowered the firm's price target on Revvity (RVTY) to $110 from $116 and keeps a Buy rating on the shares. The firm is updating its price targets for stocks under its coverage in the Life Sciences & Diagnostic Tools, LSTs, sector, the analyst tells investors. The firm notes LSTs remain under pressure as uncertainty persists with the macro environment and U.S. government policies. Recent weeks, however, have seen some signs of improvement as tariff concerns have cools slightly, the firm adds. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on RVTY: Disclaimer & DisclosureReport an Issue Revvity announces launch of three Mimix reference standards for IVD use Citi adds 'upside 90-day short-term view' on Revvity Revvity upgraded to Buy from Neutral at UBS Revvity Reports Strong Q1 2025 Financial Results Revvity's Resilience and Strategic Positioning Earns Buy Rating Amidst Macroeconomic Challenges Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Business
- Yahoo
Bruker price target lowered to $50 from $61 at BofA
BofA lowered the firm's price target on Bruker (BRKR) to $50 from $61 and keeps a Buy rating on the shares. The firm is updating its price targets for stocks under its coverage in the Life Sciences & Diagnostic Tools, LSTs, sector, the analyst tells investors. The firm notes LSTs remain under pressure as uncertainty persists with the macro environment and U.S. government policies. Recent weeks, however, have seen some signs of improvement as tariff concerns have cools slightly, the firm adds. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on BRKR: Disclaimer & DisclosureReport an Issue NIH directs staff not to end any extra research projects for now, NY Times says Bruker's Growth Potential Driven by Innovations and Strategic Cost Management Bruker acquires biocrates life sciences, terms undisclosed Bruker launches new timsUltra AIP system Bruker unveils new proteoElute nanoLC system, PepSep Advanced nLC columns
